Skip to content

Clinical trials

Celiac Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Celiac Disease Clear all

329 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20033
20042
20051
20064
20076
200813
20099
20109
201110
201212
201314
20148
201520
201620
201719
201821
201916
202021
202117
202225
202318
202415
202518
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed185
Unknown status47
Recruiting42
Terminated17
Not yet recruiting14
Active, not recruiting9
Enrolling by invitation6
Suspended5
Withdrawn3
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Palermo17
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico9
Tampere University Hospital9
9 Meters Biopharma, Inc.8
Hospital Mutua de Terrassa8
Alvine Pharmaceuticals Inc.7
Mayo Clinic7
Oslo University Hospital7
McMaster University6
Takeda6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Celiac Disease329
Crohn Disease24
Irritable Bowel Syndrome24
Colitis, Ulcerative16
Inflammatory Bowel Diseases16
Diabetes Mellitus, Type 112
Autoimmune Diseases10
Gastrointestinal Diseases10
Intestinal Diseases10
Multiple Sclerosis10

Trials

Showing 51 to 75 of 329. Each trial links to its page on Pharma Observatory.

229 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.